x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

ASGCT Podcast Network

American Society of Gene & Cell Therapy

The American Society of Gene & Cell Therapy is the premier membership organization for professionals working in cell and gene therapy. On this network, we"re sharing exciting stories from our members and the greater scientific community.

science life sciences

All Episodes

36:07

cGMP and Building Cohesive Teams with Christopher...

ASGCT Podcast Network ·

2024/11/12

Host Emily Walsh Martin, PhD, is joined by Chris Choi, PhD, Roswell Park Comprehensive Cancer Center's Senior Vice President of Industry Partnerships and Technical Director of the center’s new Good Manufacturing Practice (cGMP) Facility. Dr. Choi is also an associate professor of oncology. This wide-ranging conversation covers cell therapy development and manufacturing and how the growing Roswell Park Center is aiming to support sponsors in the CAR T and cell therapy space. Emily and Chris also

en-US

51:45

A New Era of Molecular Therapy with Joseph Glorioso, PhD

ASGCT Podcast Network ·

2024/11/05

This episode features a conversation between Dr. Roland Herzog and Dr. Joseph Glorioso. On January 1, 2025, Dr. Glorioso will begin his 5-year term as the Editor-in-Chief of Molecular Therapy, marking the end of Dr. Herzog’s successful tenure at the helm of the journal. Drs.Herzog and Glorioso engage in a wide-ranging conversation that touches on the history of Molecular Therapy, highlights from the gene and cell therapy field, and how Molecular Therapy will continue to grow and evolve under Dr

en-US

44:10

Non-AAV, Non-rare Gene Therapy with Derek Jackson,...

ASGCT Podcast Network ·

2024/10/15

Derek Jackson, vice president of cell and gene therapy product development at Pacira BioSciences, joins The Issue to take the program in a different direction. We often focus our discussions on CGT for rare diseases. Most of the time, the teams of scientists working on the program don’t have any personal experience with the disease from their family, friends, or themselves.. but today we will talk about gene therapy development for a much more common disease: knee osteoarthritis. Moreover, the

en-US

64:55

The Intersection of Ethics and Gene Therapy with Dr....

ASGCT Podcast Network ·

2024/09/17

Dr. Ben Hurlbut, professor at Arizona State University's Lincoln Center for Applied Ethics, joins host Dr. Emily Walsh Martin for a critical conversation in the cell and gene therapy industry in which they discuss how ethics informs and impacts the field and offers a deep dive into the ethical, medical, and social considerations around germline gene editing. Music by: https://www.steven-obrien.net/--------------------------Bright New Morning - Steven O'Brien (Used for free under a Creative Commons

en-US

36:21

CRISPR Editing and AAV Integration in the Brain with...

ASGCT Podcast Network ·

2024/09/10

Drs. Beverly Davidson and Bryan Simpson join Molecular Therapy EiC Dr. Roland Herzog to discuss their recent paper, Targeted long-read sequencing captures CRISPR editing and AAV integration outcomes in the brain, which was published in Molecular Therapy. ASGCT is proud to present this episode of the Molecular Therapy Podcast in partnership with our upcoming Advancing Gene and Cell Therapy for Cancer conference, which will be held on October 16 and 17 in Philadelphia and online. This landmark hybrid

en-US

48:52

CRISPR and Beyond with Vertex CSO David Altshuler,...

ASGCT Podcast Network ·

2024/07/16

Join host Emily Walsh Martin, PhD, and David Altshuler, MD, PhD, Chief Scientific Officer of Vertex Pharmaceuticals. David came to Vertex after a lengthy career in medicine and academic research. David and Emily discuss how David and the team at Vertex think about innovation in drug development and how that impacts how they select programs and approaches for the diseases they focus on. They also cover what he’d love to see happen with new cell and gene platform technologies being brought forward

en-US

34:28

Targeting STAT3 in Tumors with Oligo-PROTAC with Dr....

ASGCT Podcast Network ·

2024/07/09

Join ASGCT and the Molecular Therapy family of journals for a conversation between Drs. Paloma Giangrande and Marcin Kortylewski. They discuss a recent article published in Molecular Therapy Nucleic Acids by Dr. Kortylewski and colleagues titled "Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3." If you enjoy today’s conversation, you’ll also enjoy the upcoming ASGCT Policy Summit in Washington, DC, September 23-24. This can't-miss event brings together

en-US

35:03

AAV Capsid Production with Drs. Mario Mietzsch and...

ASGCT Podcast Network ·

2024/06/18

Dr. Daniel Stone speaks with Drs. Mario Mietzsch and Robert McKenna from the University of Florida to discuss a recent article published in the Biomanufacturing in Gene and Cell Therapy special issue of Molecular Therapy Methods & Clinical Development by Drs. Mietzsch, McKenna, and colleagues titled Production and characterization of an AAV1-VP3-only capsid: An analytical benchmark standard. If you enjoy today’s conversation, you’ll also enjoy the upcoming ASGCT Policy Summit in Washington, DC,

en-US

48:15

Gene Insertion Tech with Jason Cole, CEO of...

ASGCT Podcast Network ·

2024/06/11

In this Very Special Episode, Emily Walsh Martin, PhD explores the cutting-edge transposase-based technology presented by SalioGen at the ASGCT Annual Meeting in which they achieved gene insertion without double-strand breaks. Join us as Jason Cole, CEO at SalioGen, takes us on a captivating journey through the company's groundbreaking work, including their initial data in Stargardt disease using LNP delivery to photoreceptors.But that's not all! Discover Jason's unconventional path from small

en-US

20:51

Meet Dr. Mohamed Abou-el-Enein, Editor-in-Chief of...

ASGCT Podcast Network ·

2024/06/04

Mohamed Abou-el-Enein, MD, PhD, MSPH, the new editor-in-chief of Molecular Therapy Methods & Clinical Development (MTMCD), sits down with Scientific Editor Rory Bricker-Anthony, PhD, to discuss his vision for the journal.If you enjoy today’s conversation, you’ll also enjoy the upcoming ASGCT Policy Summit in Washington, DC, on September 23 and 24. This can't-miss event brings together policymakers and gene and cell therapy experts, including FDA leaders Julie Tierney and Nicole Verdun, PhD, to

en-US

5:42

Increasing Equitable Access with Hayley Lam, PhD

ASGCT Podcast Network ·

2024/05/14

At #ASGCT2024, Dr. Lam (CIRM) spoke during a symposium on developing CGTs with a DEI-forward approach. In this interview, she talks about incorporating DEI into the review criteria for CIRM's funded programs, how to measure DEI, and what she'd like to see in the long term for patients.Meeting registrants can watch this session (and all others) through June 21 on the virtual platform and the app! Host: Lynnea Olivarez, incoming Communications Commmittee ChairShow your support for ASGCT!:

en-US

4:39

An Explosive Year for Gene Therapy with ASGCT...

ASGCT Podcast Network ·

2024/05/11

As she begins her tenure as ASGCT President, Paula Cannon, PhD (USC), tells host Lynnea Olivarez, incoming chair of the Communications Committee, why she's excited to take the reins for the Society. Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

en-US

6:06

Reporting on Regulatory Considerations with...

ASGCT Podcast Network ·

2024/05/10

Jef Akst, managing editor at BioSpace, talks about the major CGT issues she's been covering at #ASGCT2024 including regulatory considerations and AAV manufacturing. She also tells host Lynnea Olivarez what she hopes to be reporting on next year at the ASGCT Annual Meeting in New Orleans! Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

en-US

5:49

CNS Gene Therapies with Todd Carter, PhD

ASGCT Podcast Network ·

2024/05/10

Todd Carter, PhD (CSO at Voyager Therapeutics) talks with incoming Communications Committee Chair Lynnea Olivarez about changes in the approach to developing gene therapies for CNS disorders like Huntington's disease.Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

en-US

6:07

New Frontiers in Hemophilia Treatments with Lindsey...

ASGCT Podcast Network ·

2024/05/10

ASGCT Board of Directors member Lindsey George, MD, (Children's Hospital of Philadelphia) discusses the dramatic advancements in available treatment options for patients with hemophilia and the responsibility of scientists and clinicians in guiding patients through these once-in-a-lifetime decisions. Host: Lynnea Olivarez, incoming chair of the ASGCT Communications CommitteeShow your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

en-US

4:26

Cystic Fibrosis Gene Therapies with CDA Winner Ashley...

ASGCT Podcast Network ·

2024/05/10

Incoming ASGCT Communications Committee chair Lynnea Olivarez catches up with ASGCT Career Development Award winner Ashley Cooney, PhD, (University of Iowa) to discuss her work in vector-delivered airway gene transfer and use of saline solution to "dramatically increase" gene transfer.Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

en-US

5:33

Patient Advocacy with Leah Myers + Jenny Burke

ASGCT Podcast Network ·

2024/05/08

Leah Myers, Executive Director of the FamilieSCN2A Foundation, and Jenny Burke, who sits on the organization's board, talk about the importance of empowering patients and families affected by genetic diseases. Host: Lynnea OlivarezShow your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

en-US

6:06

Stem Cell Therapy with Charles Murry, MD, PhD

ASGCT Podcast Network ·

2024/05/08

Dr. Murry talks about his early work reprogramming injured heart cells, his vision for the future of organ regeneration, and the privilege of getting paid to be curious. Host: Lynnea OlivarezShow your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

en-US

4:33

Communicating the Science with Benjamin McLeod

ASGCT Podcast Network ·

2024/05/08

"Storytelling is completely underrated in science," says Benjamin McLeod, a lab scientist-turned-communicator. Listen to him talk about the importance of presenting CGT research in a narrative format. Host: Lynnea OlivarezShow your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

en-US

5:14

New Technologies for Gene Targeting + Gene Correction...

ASGCT Podcast Network ·

2024/05/07

In this episode, host Lynnea Olivarez talks with David Segal, PhD, an abstract session co-chair at the ASGCT Annual Meeting. Dr. Segal discusses new technologies that he says have moved from academia to industry, and, hopefully soon, to rare disease patients. Miss a session? Catch it on demand on the virtual platform for 30 days following the conclusion of the meeting!Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

en-US

65 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter